ScienceDex / Researcher record
Packard, Alan Brent
- Viewpoint Molecular Targeting, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2004 | $268,386 | 1 | #21,640 |
| 2005 | $230,040 | 1 | #24,612 |
| 2022 | $990,225 | 1 | #9,987 |
| 2023 | $961,450 | 1 | #10,762 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20041 record
- FY20051 record
- FY20221 record
- FY2023 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2004 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Packard, Alan Brent as a PI. Multi-PI records show the full award amount for context.
- 5R44CA268314-02R44Contact PIImage-guided dosimetry-based alpha particle therapy for neuroblastoma.$961.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing Packard, Alan Brent as a PI.
FY2023 award administered by Viewpoint Molecular Targeting, Inc. (IA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2004First NIH AwardViewpoint Molecular Targeting, Inc.
- 2022$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #9987
- 2023$2M Cumulative Funding